Brukinsa

Digital Pharmacist

The RxWiki Digital Pharmacist stamp of approval lets you know that this content has been created and reviewed by a licensed pharmacist.

Brukinsa is used to treat mantle cell lymphoma (MCL), an often aggressive, rare form of non-Hodgkin lymphoma.

Brukinsa Overview

Reviewed: April 21, 2020
Updated: 

Brukinsa is a prescription medicine used to treat adults with mantle cell lymphoma (MCL) who have received at least one prior treatment for their cancer. Brukinsa belongs to a group of drugs called BTK inhibitors. Bruton's tyrosine kinase (BTK) is a protein that signals to cancerous B cells, helping them to grow and spread. Blocking BTK can help stop this signaling.

This medication comes in capsule form. It is taken once or twice daily. Swallow Brukinsa capsules whole with a glass of water. Do not open, break, or chew the capsules.

Common side effects include decreased blood cell and platelet counts, rash, diarrhea, and upper respiratory infections.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Brukinsa Drug Class

Back to Top

Brukinsa is part of the drug class: